Thought Leader: Late-Breaking Studies That Will Change Your Practice

Sunday, March 22, 2026

1:30 PM - 2:15 PM Central Time

Location: Skyline Ballroom, W375ABC

CE: 0.75

Late Breaker Thought Leader Moderator(s)

JS

Jonathan Sevransky, MD, MHS, FCCM

Emory University Hospital, Georgia

Disclosure(s): Regeneron: Clinical Trial Investigator (Ongoing), Grant/Research Support (Ongoing)
Tamas Szakmany, MD, PhD, MBE, FCCM (he/him/his)

Cleveland Clinic Abu Dhabi, United Arab Emirates

Disclosure information not submitted.
KW

Kristin Walter, MD

Disclosure(s): No relevant financial relationship(s) to disclose.

Evaluate the effect of a novel ceragenin‑coated endotracheal tube on ventilator-associated pneumonia incidence and patient‑centered outcomes
Explain the rationale for developing a standardized, electronic health record-based pediatric sepsis event surveillance definition, including adapting elements of the 2024 Phoenix pediatric sepsis criteria for scalable national surveillance
Discuss results of the Study of Whole Blood in Frontline Trauma, which compared whole blood with separate red cells and plasma in the prehospital setting

1:30 PM - 1:45 PM Central Time

Ceragenin-Coated Endotracheal Tubes for the Reduction of Ventilator-Associated Pneumonia: A Prospective, Longitudinal, Crossover, Interrupted-Time, Implementation Study (CEASE VAP)
John Muscedere, MD (he/him/his)
1:45 PM - 2:00 PM Central Time

National Estimates of Pediatric Sepsis in U.S. Hospitals Using Clinical Data: Pediatric Sepsis Event Surveillance in U.S. Hospitals
Chanu Rhee, MD, MPH, FCCM (he/him/his) – Harvard Medical School
Scott L. Weiss, MD, FCCM – Nemours Childrens Hospital
2:00 PM - 2:15 PM Central Time

Prehospital Whole Blood in Traumatic Hemorrhage
Laura Green, MBBS, FRCP, MD (she/her/hers)